Related Experiment Video
Updated: Mar 27, 2026
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
High-throughput Functional Genomics Identifies Regulators of Primary Human Beta Cell Proliferation
Karine Robitaille1, Jillian L Rourke2, Joanne E McBane1
1From the Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario K1H 8L1.
Abstract:
The expansion of cells for regenerative therapy will require the genetic dissection of complex regulatory mechanisms governing the proliferation of non-transformed human cells. Here, we report the development of a high-throughput RNAi screening strategy specifically for use in primary cells and demonstrate that silencing the cell cycle-dependent kinase inhibitors CDKN2C/p18 or CDKN1A/p21 facilitates cell cycle entry of quiescent adult human pancreatic beta cells. This work identifies p18 and p21 as novel targets for promoting proliferation of human beta cells and demonstrates the promise of functional genetic screens for dissecting therapeutically relevant state changes in primary human cells.
Insights
Scientists developed a new RNAi screening method for primary cells. Silencing cell cycle inhibitors p18 and p21 helps quiescent human beta cells proliferate, offering new therapeutic targets for regenerative medicine.
Area of Science:
- Cell Biology
- Regenerative Medicine
- Genetics
Background:
- Regenerative therapy requires understanding and controlling the proliferation of non-transformed human cells.
- Complex regulatory mechanisms govern cell proliferation, posing challenges for therapeutic applications.
- Primary cells, particularly quiescent adult human pancreatic beta cells, are critical for regenerative strategies but difficult to expand.
Purpose of the Study:
- To develop a high-throughput RNAi screening strategy applicable to primary human cells.
- To identify genetic targets that can promote the proliferation of quiescent adult human pancreatic beta cells.
- To explore the therapeutic potential of functional genetic screens in primary cells.
Main Methods:
- Development of a high-throughput RNA interference (RNAi) screening strategy.
- Application of the screening strategy to primary human cells, specifically quiescent adult pancreatic beta cells.
- Genetic dissection of regulatory mechanisms controlling cell proliferation.
Main Results:
- Successful development and implementation of a high-throughput RNAi screen for primary cells.
- Silencing of cyclin-dependent kinase inhibitors CDKN2C/p18 or CDKN1A/p21 was shown to facilitate cell cycle entry in quiescent adult human pancreatic beta cells.
- Identification of p18 and p21 as novel targets for promoting human beta cell proliferation.
Conclusions:
- p18 and p21 are identified as key targets for enhancing human beta cell proliferation.
- The developed high-throughput RNAi screening strategy is effective for dissecting therapeutically relevant state changes in primary human cells.
- This approach holds promise for advancing regenerative therapies by enabling the expansion of critical primary cell populations.
